COMMUNIQUÉS West-GlobeNewswire

Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026
27/07/2026
Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026 Mont-Saint-Guibert, Belgium – July 27, 2026, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), [...]
Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026
27/07/2026
SAN DIEGO, July 27, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Monday, August 10, 2026, at 4:30 p.m. Eastern Time to report [...]
Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer
27/07/2026
Dr. Rooney, former immunology leader at Johnson & Johnson, will lead clinical development strategy across Kymera’s industry-leading oral immunology portfolio Jared Gollob, MD, will retire from his role after eight [...]
STERIS to Host a Conference Call for Fiscal 2027 First Quarter on August 6, 2026
27/07/2026
DUBLIN, IRELAND, July 27, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2027 first quarter results at 9:00 a.m. ET [...]
Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026
27/07/2026
SOUTH SAN FRANCISCO, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that it will report financial results and business highlights for the second quarter ended June 30, [...]
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
27/07/2026
RADNOR, Pa., July 27, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in [...]
Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement
27/07/2026
ALAMEDA, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Scribe Therapeutics Inc. (“Scribe Therapeutics”) (Nasdaq: SCTX), a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed [...]
Nyxoah Publiera ses Résultats Financiers du Deuxième Trimestre 2026 le 5 août 2026
27/07/2026
Nyxoah Publiera ses Résultats Financiers du Deuxième Trimestre 2026 le 5 août 2026 Mont-Saint-Guibert, Belgique – 27 juillet 2026, 22h05 CET / 16h05 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq : NYXH) (« Nyxoah » ou la « [...]
Philips delivers solid comparable sales growth and margin in Q2; reiterates full year comparable sales growth outlook; Adjusted EBITA and free cash flow outlook increased to reflect US tariff refund
27/07/2026
July 27, 2026 Q2 2026 Group performance Comparable order intake declined 1%, due to timing of certain large orders Group sales of EUR 4.4 billion, reflecting 4% comparable sales growth Income from operations of EUR 609 [...]
Atalante X, Wandercraft’s Self-Balancing Rehabilitation Exoskeleton, Receives ARCSA Clearance in Ecuador, Advancing Latin American Expansion
27/07/2026
Clearance broadens access to hands-free, overground robotic gait training in Ecuador, and supports Wandercraft’s plans to expand advanced rehabilitation technology across Latin America NEW YORK and QUITO, Ecuador, July [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 30 - 2026
27/07/2026
Aggregated presentation by day and by market Weekly report on share repurchases from 20th July to 24th July 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument [...]
Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels
27/07/2026
Digital subscription platform brings together the Company’s proprietary consumer health products across consumer (B2C) and corporate (B2B) channels Customers can begin through one of three paths: a free nutritionist [...]
Elevar Therapeutics Announces Three Abstracts Accepted for Presentation at ESMO Congress 2026
27/07/2026
FORT LEE, N.J., July 27, 2026 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 30 - 2026
27/07/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 20 juillet au 24 juillet 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction [...]
ORYZON Reports Financial Results and Corporate Update for Half Year Ended June 30th, 2026
27/07/2026
Positive clinical data presented at EHA for iadademstat in first line acute myeloid leukemia (AML); iadademstat+azacitidine+venetoclax resulted in 100% ORR, 89% CRc and 78% CR, including in patients with TP53 or RAS [...]
Landmark 10-Year Study Strengthens Long-Term Evidence Supporting Focal Therapy
27/07/2026
Independent research from a UK group demonstrates durable long-term tissue ablation, while Sonablate’s extensive clinical use reflects its role in advancing HIFU technology worldwide CHARLOTTE, N.C., July 27, 2026 ( [...]
Revagenix Doses First Participant in Phase 1 Trial of Rev-56, an Inhaled Therapy for Non-CF Bronchiectasis
27/07/2026
— Potential first therapy to target chronic Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis — Chronic Pseudomonas is a key driver of inflammation, exacerbations, and disease progression in bronchiectasis — [...]
Parexel Recognized as a World’s Top Disability Inclusive Business by the Disability Index® from Disability:IN
27/07/2026
Reflecting company’s commitment to advancing inclusion and accessibility across its global workforce and in its clinical trials RALEIGH, N.C., July 27, 2026 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical [...]
HealthEx Launches HealthEx Wallet, a Secure App for Individuals to Access, Understand, and Manage Their Health Records
27/07/2026
Now available to individuals across HealthEx’s partner ecosystem, in the Medicare App Library, and launching soon directly from HealthEx WASHINGTON, July 27, 2026 (GLOBE NEWSWIRE) -- CMS Health Technology Ecosystem [...]

Pages